Trial Profile
Effect of cholinergic precursor choline alfoscerate on cognitive and behavioral symptoms in patients with mild cognitive impairment (mild cognitive impairment) [Effetto del precursore colinergico colina alfoscerato sui sintomi cognitivi e comportamentali in pazienti affetti da danno cognitivo lieve (mild cognitive impairment) Effetto del precursore colinergico colina alfoscerato sui sintomi cognitivi e comportamentali in pazienti affetti da danno cognitivo lieve (mild cognitive impairment)]
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Feb 2014
Price :
$35
*
At a glance
- Drugs Choline alfoscerate (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- Sponsors MDM SpA
- 28 Feb 2014 New trial record